American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting

Journal of Clinical Oncology

Volumn 24, Issue 31, 2006, Pages 5091-5097

  Khatcheressian, James L ^a   Wolff, Antonio C ^a   Smith, Thomas J ^a   Grunfeld, Eva ^a   Muss, Hyman B ^a   Vogel, Victor G ^a   Halberg, Francine ^a   Somerfield, Mark R ^a   Davidson, Nancy E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18; TUMOR MARKER;

BONE SCINTISCANNING; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER RECURRENCE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENETIC COUNSELING; HUMAN; MAMMOGRAPHY; MEDICAL LITERATURE; MEDICAL SOCIETY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT EDUCATION; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SELF EXAMINATION; THORAX RADIOGRAPHY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ANAMNESIS; ARTICLE; BREAST TUMOR; EXPERT WITNESS; GENETICS; HEALTH SURVEY; MASS SCREENING; METHODOLOGY; ONCOLOGY; PALPATION; PATIENT REFERRAL; STANDARD; TIME;

BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; EXPERT TESTIMONY; FEMALE; GENETIC COUNSELING; HUMANS; MAMMOGRAPHY; MASS SCREENING; MEDICAL HISTORY TAKING; MEDICAL ONCOLOGY; PALPATION; PHYSICAL EXAMINATION; POPULATION SURVEILLANCE; RADIOTHERAPY, ADJUVANT; REFERRAL AND CONSULTATION; SOCIETIES, MEDICAL; TIME FACTORS;

EID: 33750935710     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.08.8575     Document Type: Review

References (30)

1. American Society of Clinical Oncology: Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol 14:671-679, 1996
2. Mille D, Roy T, Carrere MO, et al: Economic impact of harmonizing medical practices: Compliance with clinical practice guidelines in the follow-up of breast cancer in a French Comprehensive Cancer Center. J Clin Oncol 18:1718-1724, 2000
3. Grunfeld E, Mant D, Yudkin P, et al: Routine follow up of breast cancer in primary care: Randomised trial. BMJ 313:665-669, 1996
4. Loprinzi CL, Hayes D, Smith T: Doc, shouldn't we be getting some tests? J Clin Oncol 18:2345-2348, 2000
5. Rojas MP, Telaro E, Russo A, et al: Follow-up strategies for women treated for early breast cancer. Oxford, United Kingdom, Cochrane Library, CD001768, 1, 2005
6. The GIVIO Investigators: Impact of follow-up testing on survival and health-related quality of life in breast cancer patients: A multicenter randomized controlled trial. JAMA 271:1587-1592, 1994
7. Gulliford T, Opomu M, Wilson E, et al: Popularity of less frequent follow up for breast cancer in randomised study: Initial findings from the hotline study. BMJ 314:174-177, 1997
8. Rosselli Del Turco M, Palli D, Cariddi A, et al: Intensive diagnostic follow-up after treatment of primary breast cancer: A randomized trial - National Research Council Project on Breast Cancer Follow-Up. JAMA 271:1593-1597, 1994
9. Grunfeld E, Dhesy-Thind S, Levine M: Clinical practice guidelines for the care and treatment of breast cancer: Follow-up after treatment for breast cancer (summary of the 2005 update). CMAJ 172: 1319-1320, 2005
10. US Preventive Services Task Force: Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Recommendation statement. Ann Intern Med 143:355-361, 2005
11. Olivotto IA, Bajdik CD, Ravdin PM, et al: Population-based validation of the prognostic model ADJUVANT! for early breast cancer. J Clin Oncol 23:2716-2725, 2005
12. de Bock GH, Bonnema J, van der Hage J, et al: Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: A meta-analysis and systematic review. J Clin Oncol 22:4010-4018, 2004
13. Thomas DB, Gao DL, Ray RM, et al: Randomized trial of breast self-examination in Shanghai: Final results. J Natl Cancer Inst 94:1445-1457, 2002
14. Grunfeld E, Noorani H, McGahan L, et al: Surveillance mammography after treatment of primary breast cancer: A systematic review. Breast 11:228-235, 2002
15. Grunfeld E, Fitzpatrick R, Mant D, et al: Comparison of breast cancer patient satisfaction with follow-up in primary care versus specialist care: Results from a randomized controlled trial. Br J Gen Pract 49:705-710, 1999
16. Grunfeld E, Yudkin P, Adewuyl-Dalton R, et al: Follow up in breast cancer: Quality of life unaffected by general practice follow up. BMJ 311:54, 1995
17. Grunfeld E, Gray A, Mant D, et al: Follow-up of breast cancer in primary care vs specialist care: Results of an economic evaluation. Br J Cancer 79:1227-1233, 1999
18. Grunfeld E, Levine MN, Julian JA, et al: Randomized trial of long-term follow-up for early-stage breast cancer: A comparison of family physician versus specialist care. J Clin Oncol 24:848-855, 2006
19. Early Breast Cancer Trialists' Collaborative Group: Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 365:1687-1717, 2005
20. Institute of Medicine and National Research Council, Committee on Cancer Survivorship: Improving Care and Quality of Life, National Cancer Policy Board. From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC, National Academies Press, 2005
21. Palli D, Russo A, Saieva C, et al: Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial - National Research Council Project on Breast Cancer Follow-Up. JAMA 281:1586, 1999
22. Joseph E, Hyacinthe M, Lyman GH, et al: Evaluation of an intensive strategy for follow-up and surveillance of primary breast cancer. Ann Surg Oncol 5:522-528, 1998
23. Hortobagyi GN: Can we cure limited metastatic breast cancer? J Clin Oncol 20:620-623, 2002
24. Drotman MB, Machnicki SC, Schwartz LH, et al: Breast cancer: Assessing the use of routine pelvic CT in patient evaluation. Am J Roentgenol 176:1433-1436, 2001
25. Hurria A, Leung D. Trainor K, et al: Screening chest imaging studies are not effective in the follow-up of breast cancer patients. J Oncol Manag 12:13-15, 2003
26. Vranjesevic D, Filmont JE, Meta J, et al: Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients. J Nucl Med 43:325-329, 2002
27. Kamel EM, Wyss MT, Fehr MK, et al: [18F]-Fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer. J Cancer Res Clin Oncol 129:147-153, 2003
28. Isasi CR, Moadel RM, Blaufox MD: A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases. Breast Cancer Res Treat 90:105-112, 2005
29. Kuhl CK, Schrading S, Leutner CC, et al: Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23:8469-8476, 2005
30. Leach MO, Boggis CR, Dixon AK, et al: Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: A prospective multicentre cohort study (MARIBS). Lancet 365:1769-1778, 2005